Aurobindo Pharma Q3 Earnings: Profit Surges 7% to Rs 910 Cr, Revenue Climbs 8%

Entertainment National Sports Markets Business & Economy Lifestyle World Astrology & Religion Technology Education & Jobs Auto Politics Viral Opinions

Loading more articles...

Aurobindo Pharma Q3 Profit Jumps 7% to Rs 910 Cr, Revenue Up 8%

Aurobindo Pharma Q3 Profit Jumps 7% to Rs 910 Cr, Revenue Up 8%

C

CNBC Awaaz•09-02-2026, 20:34

Aurobindo Pharma Q3 Profit Jumps 7% to Rs 910 Cr, Revenue Up 8%

•Aurobindo Pharma reported a 7.5% year-on-year increase in net profit to Rs 909.8 crore, falling slightly short of market estimates.
•Revenue grew by 8.4% to Rs 8,646 crore, surpassing market expectations.
•EBITDA rose 12.4% to Rs 1,773.6 crore, exceeding estimates, with margins improving to 20.5%.
•The company invested approximately $80 million in net capex for capacity expansion and new business development.
•Aurobindo Pharma received approval for 7 products and launched 9 products in the US market during the quarter.

Read Full Article on Cnbc in Hindi

✦

More like this

✦

More like this

Aurobindo Pharma Q3 Net Profit Jumps 23.31% Despite Sales Dip

Aurobindo Pharma Q3 Net Profit Jumps 23.31% Despite Sales Dip

Aurobindo Pharma Q3 Net Profit Jumps 8% on Europe, ARV Growth

Aurobindo Pharma Q3 Net Profit Jumps 8% on Europe, ARV Growth

Representational image (Image: News18)

Aurobindo Pharma Q3 Profit Jumps 8% to Rs 910 Cr on Strong Sales

Aurobindo Pharma Shares Surge Post Q3 Results, Street Awaits Management Commentary

Aurobindo Pharma Shares Surge Post Q3 Results, Street Awaits Management Commentary

Natco Pharma Q3 Profit Jumps 14.3% to ₹152 Cr, Revenue Up 36%

Natco Pharma Q3 Profit Jumps 14.3% to ₹152 Cr, Revenue Up 36%

Marksans Pharma Sees Strong Q3 Growth: Net Sales Up 8.93%, Profit Jumps 9.82%

Marksans Pharma Sees Strong Q3 Growth: Net Sales Up 8.93%, Profit Jumps 9.82%